GSK-3β activation is required for ZIP-induced disruption of learned fear

Sukwoon Song1, Jihye Kim1, Kyungjoon Park2

  • 1School of Biological Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea.

Scientific Reports
|October 27, 2020
PubMed

Insights

The myristoylated zeta inhibitory peptide (ZIP) triggers memory loss by activating glycogen synthase kinase 3 beta (GSK-3β). Inhibiting GSK-3β prevents this memory disruption, revealing a new mechanism for memory erasure.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Memory Research

Background:

  • The myristoylated zeta inhibitory peptide (ZIP) is known to cause memory loss.
  • ZIP's mechanism is unclear as it affects memory even without its presumed target, protein kinase Mζ (PKMζ).

Purpose of the Study:

  • To elucidate the mechanism by which ZIP induces memory loss.
  • To identify the molecular targets of ZIP involved in memory erasure.

Main Methods:

  • A kinome-wide screen was employed to identify ZIP-activated kinases.
  • In vitro and in vivo experiments using GSK-3β inhibitors (BIO-acetoxime) and knockdown (shRNA) were performed.
  • Synaptic plasticity (depotentiation) and learned fear responses were assessed.

Main Results:

  • Glycogen synthase kinase 3 beta (GSK-3β) was found to be activated by ZIP.
  • ZIP-induced depotentiation of synaptic potentiation was blocked by a GSK-3β inhibitor.
  • Inhibition or knockdown of GSK-3β in the lateral amygdala (LA) attenuated ZIP's disruption of learned fear.
  • Expressing a non-inhibitable GSK-3β in the LA decreased conditioned fear.

Conclusions:

  • GSK-3β activation is a crucial mediator of ZIP-induced memory disruption.
  • This study reveals a novel role for GSK-3β in the cellular mechanisms underlying memory erasure.